Spastic gait analysis. Contribution of the motion lab;Analyse de la marche spastique. Contribution du laboratoire d'analyse du mouvement

Neurochirurgie

Volumn 49, Issue 2-3 II, 2003, Pages 215-225

  Remy Neris O ^a,c   Bouilland, S ^a   Bussel, B ^b  

^a Laboratoire d'Analyse du Mouvement   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c Centre J Calve Fondation Hopale   (France)

Author keywords

Gait; Hypertonia; Motion analysis; Spasticity

Indexed keywords

CALCULATION; CONFERENCE PAPER; ELECTROMYOGRAM; ELECTRONICS; GAIT; HISTORY OF MEDICINE; HUMAN; KINEMATICS; KINETICS; LEG MOVEMENT; MOTION; MOTOR DYSFUNCTION; MUSCLE CONTRACTION; SENSORY DYSFUNCTION; SPASTICITY;

BIOMECHANICS; ELECTROMYOGRAPHY; GAIT; HUMANS; MOTOR NEURON DISEASE; MOVEMENT; MUSCLE SPASTICITY;

EID: 0037728997     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. MAREY EJ. La machine animal. Paris: Germer Baillière, 1873.
2. BRAUNE W, FISCHER O. Über den schwerpunkt des menschlichen körpers und seiner glieder. Abhandl Math Phys Kl K Sächs Gesellsch Wissensch 1892; 18: 409-492.
3. AMAR J. Trottoir dynamographique. In: CR Acad Sci, 1916.
4. BRESLER B, FRANKEL JP. Forces and moments in the leg during walking. Trans Am Soc Mech Eng 1950; 72: 27-36.
5. CUNNINGHAM D, BROWN GW. Two devices for measuring the forces acting on the hyman body during walking. Proc Soc Exp Stress Anal 1952; 9: 75-90.
6. EBERHART H. Fundamental studies of human locomotion and other information relating to design of articifical limbs. Report to US Veterans' association 1947.
7. PAUL JP. Forces transmitted by joints in the human body. Proc Inst Mech Eng 1967; 181: 8-15.
8. FURNÉE EH, Hybrid instrumentation in prosthetics research. In: 7th International Conference on Medical and Biological Engineering, Stockholm, 1967.
9. PAUL JP, JARETT MO, ANDREWS BJ. Quantitative analysis of locomotion using television, In: World Congress of the International Society for Prosthetics and Orthotics, Montreux, 1974.
10. MCGIBBON CA, RILEY PO, KREBS DE. Comparison of hip center estimation using in-vivo and ex-vivo measurements from the same subject. Clin Biomech (Bristol, Avon) 1997; 12: 491-495.
11. HATZE H. A complete set of control equations for the musculo-skeletal system. J Biomech 1977; 10: 799-805.
12. CRENNA P, INVERNO M. Objective detection of pathophysiological factors contributing to gait disturbance in supraspinal lesions. In: Fedrizzi E, Avanzini G, Crenna P, eds. Motor development in children. London: John Libbey & Company Ltd, 1994: 103-118.
13. CRENNA P. Spasticity and 'spastic' gait in children with cerebral palsy. Neurosci Behav Rev 1998; 22: 571-578.
14. LANCE JW. Symposium synopsis. In: Feldmann RG, Young RR, Koella W, eds. Spasticity: disordered motor control. Chicago: Year Book Medical, 1980: 185-230.
15. ASHWORTH B. Preliminary trial of carisprodol in multiple sclerosis. Practitionner 1964; 192: 540-542.
16. DENNY-BROWN D. Historical aspects of the relation of spasticity to movement. In: Feldmann RG, Young RR, Werner PK, eds. Spasticity: disordered motor control. Chicago: Symposia Specialists Inc. 1, 1980: 1-15.
17. DIETZ V, QUINTERN J, BERGER W. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 1981; 104: 431-449.
18. DE QUERVAIN IA, et al. Gait pattern in the early recovery period after stroke. J Bone Joint Surg Am 1996; 78: 1506-1514.
19. GIULIANI CA. Adult hemiplegic gait. In: Smidt GL, ed. Gait in rehabilitation. New york: Churchill Linvingstone, 1990: 253-266.
20. BANTA JV. The evolution of gait analysis: a treatment decision-making tool. Conn Med 2001; 65: 323-331,
21. BADDAR A, et al. Ankle and knee coupling in patients with spastic diplegia: effects of gastrocnemius-soleus lengthening. J Bone Joint Surg Am 2002; 84-A: 736-744.
22. ZURCHER AW, MOLENAERS G, DESLOOVERE K, FABRY G. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy. Acta Orthop Belg 2001; 67: 475-480.
23. ZWICK EB, SARAPH V, STROBL W, STEINWENDER G. [Single event multilevel surgery to improve gait in diplegic cerebral palsy - a prospective controlled trial]. Z Orthop Ihre Grenzgeb 2001; 139: 485-489.
24. PERRY J. Normal and pathological gait. Atlas of Orthotics. 2nd ed. Saint Louis: Mosby CV, 1985.
25. CASEY-KERRIGAN D, ROTH SR, RILEY PO. The modelling of adult spastic paretic stiff-legged gait swing period based on actual kinematic data. Gait Posture 1998; 7: 117-124.
26. GAGE JR. Surgical treatment of knee dysfunction in cerebral palsy. Clin Orthop 1990; (n°253): 45-54.
27. WATERS RL, et al. Stiff-legged gait in hemiplegia: surgical correction. J Bone Joint Surg Am 1979; 61: 927-933.
28. GAGE JR. Gait analysis in cerebral palsy. New York: Mac Kenneth Press, 1991: 206.
29. KERRIGAN DC, FRATES EP, ROGAN S, RILEY PO. Spastic paretic stiff-legged gait: biomechanics of the unaffected limb. Am J Phys Med Rehabil 1999; 78: 354-360.
30. STEINWENDER G, et al. Intrasubject repeatability of gait analysis data in normal and spastic children. Clin Biomech (Bristol, Avon) 2000; 15: 134-139.
31. LIN CJ, et al. Common abnormal kinetic patterns of the knee in gait in spastic diplegia of cerebral palsy. Gait Posture 2000; 11: 224-232.
32. GUGENHEIM JJ, ROSENTHAL RK, SIMON SR. Knee flexion deformities and genu recurvatum in cerebral palsy: roentgenographic findings. Dev Med Child Neurol 1979; 21: 563-570.
33. ORSNES GB, SORENSEN PS, LARSEN TK, RAVNBORG M. Effect of baclofen on gait in spastic MS patients. Acta Neurol Scand 2000; 101: 244-248.
34. CORSTON RN, JOHNSON F, GODWIN-AUSTEN RB. The assessment of drug treatment of spastic gait. J Neurol Neurosurg Psychiatry 1981; 44: 1035-1039.
35. WISSEL J, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics 1999; 30: 120-124.
36. WILSON DJ, CHILDERS MK, COOKE DL, SMITH BK. Kinematic changes following botulinum toxin injection after traumatic brain injury. Brain Inj 1997; 11: 157-167.
37. GERSZTEN PC, ALBRIGHT AL, BARRY MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 1997; 27: 40-44.
38. DAN B, BOUILLOT E, BENGOETXEA A, CHERON G. Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis. Neurosci Lett 2000; 280: 175-178.
39. DECO P, et al. Soleus neurotomy for treatment of the spastic equinus foot. Groupe d'Évaluation et de Traitement de la Spasticité et de la Dystonie. Neurosurgery 2000; 47: 1154-1161.
40. ZURCHER AW, MOLLENAERS G, DESLOOVERE K, FABRY G. Kinematic and kinetic evaluation of the ankle after intra muscular injection of Botulinum toxin A in children with cerebral palsy. Acta Orthop Belg 2001; 67: 475-480.
41. SUBRAMANIAN N, VAUGHAN CL, PETER JC, ARENS LJ. Gait before and 10 years after rhizotomy in children with cerebral palsy spasticity. J Neurosurg 1998; 88: 1014-1019.
42. WRIGHT FV, et al. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Dev Med Child Neurol 1998; 40: 239-247.
43. DIETZ V, TRIPPEL M, BERGER W. Reflex activity and muscle tone during elbow movements in patients with spastic paresis. Ann Neurol 1991; 30: 767-779.
44. CARLSOO S, DAHLOF AG, HOLM J. Kinetic analysis of the gait in patients with hemiparesis and in patients with intermittent claudication. Scand J Rehabil Med 1974; 6: 166-179.
45. KNUTSSON E, MARTENSSON A. Dynamic motor capacity in spastic paresis and its relation to prime mover dysfunction, spastic reflexes and antagonist co-activation. Scand J Rehabil Med 1980; 12: 93-106.
46. FRIGO C, CRENNA P, JENSEN LM. Moment angle relationship at lower limbs joints during human walking at different velocities. J Electromyogr Kinesiol 1996; 6: 177-190.